Acrospire Investment Management’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

Acrospire Investment Management’s Portfolio ANAC Stock Details ANAC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-500	Closed	-$27K	–	2492
2016 Q1	$27K	Buy	+500	New	+$36.9K	0.02%	1394

Other funds holding ANAC

KCM

Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

CIM

CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

Acrospire Investment Management's ANAC Position: Q2 2016 in Review

Acrospire Investment Management sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 500 shares — an estimated $27K sold.

Acrospire Investment Management first reported a position in ANAC in Q1 2016 and held it in 1 quarter. The position peaked at $27K in Q1 2016. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

Acrospire Investment Management reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
Acrospire Investment Management sold 500 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $27K.
Acrospire Investment Management first reported a position in ANACOR PHARMACEUTICALS INC COM in Q1 2016 and held it in 1 quarter.
Acrospire Investment Management's ANACOR PHARMACEUTICALS INC COM position peaked at $27K in Q1 2016.
2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on Acrospire Investment Management's 13F filing for Q2 2016, filed 9 Aug 2016.